May 13, 2020
Less than a week after the first home-collected saliva test for COVID-19 was authorized by the FDA, at least two consumer-facing telehealth brands say they have cut deals to sell these test kits to the public.
The first is consumer telehealth company Hims & Hers, best known for its mail-order wellness and sexual health products for men and women.
While the well-funded startup has...
April 8, 2020
Easy access to (temporarily) free counseling. Consumer telehealth and mail-order prescription services Hims and Hers are dipping into the mental health wellness space. The brands kicked off new anonymized group therapy and guided meditation offerings yesterday, with the therapy sessions led by a licensed mental health practitioner.
The group sessions are currently being offered free of charge in...
November 14, 2019
Hims & Hers, an online mail-order health company that uses remote consultations to prescribe cosmetic and sexual health products, has rolled out a new app for users.
The app will offer almost identical services and links as the original platform, and will give users access to asynchronous healthcare visits and prescription products such as birth control and erectile dysfunction medication...
October 1, 2019
Sixth time's the charm? Roche’s Accu-Chek Connect Diabetes Management App has notched its sixth device recall from the FDA, this time due to meter-to-app data transfer issues for users with Android OS 8.0 and above. According to the agency’s posting, Roche notified partners, users and call centers of the issue and released and update addressing the problem before the end of that month.
September 12, 2019
There are some striking similarities between mail-order sexual health companies Ro and Hims: Both started out focused on men’s sexual health, both employ telemedicine and if you ride the subway in a major city you’ve probably seen their advertisements.
But things are getting heated this week after Hims launched an updated version of its platform. On Tuesday, Ro cofounder Zachariah Reitano...
July 29, 2019
Direct-to-consumer telemedicine services have attracted plenty of attention from investors and patients alike, due in part to their lower costs and ease of use. From a medical standpoint, however, these business models introduce a number of departures from traditional care that deserve serious concern and investigation, argue the authors of an editorial published Friday in JAMA.
July 11, 2019
Telehealth and mail-order health and wellness consumer brands Hims & Hers have been joined by Dr. Pat Carroll. Formerly a chief medical officer at Walgreens and a 20,000-patient primary care group, Carroll take on a similar role for the growing startup.
“Our vision is an ecosystem where people have plenty of options to get the care that’s right for them. Depending on what they need, that...
April 15, 2019
Within the last decade, shopping for groceries, clothes and books has become a lot more virtual. The digital space is rapidly replacing brick and mortar stores for many customers. Now consumers are turning to the web for their health products—whether it is to get a pharmacy prescription, a urine test or an “embarrassing” sexual health product. Read on for three emerging trends in the digital mail...
January 29, 2019
Hims — an online mail-order men’s health company that uses remote consultation to prescribe cosmetic and sexual health products — has landed $100 million in new funding, according to the publication Recode, which first published the scoop this morning. Following the investment, the company will be valued at $1 billion.
This news comes shortly after the San Francisco-based company launched Hers,...
November 5, 2018
Hims, an online mail-order men’s health company that incorporates remote consultations for prescription products, is looking to double its potential customer base with the launch of a similar product line and service targeting women.
“Hers” will offer a range of hair, skin and sexual health products for online order and delivery. Much like its male counterpart, ordering a product that requires a...